
Closing Bell: Moderna Gains, Dick's Sporting Goods Falls, Target Declines
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostic, Emily Graffeo, Norah Mulinda, Tim Stenovec
- Moderna (MRNA) shares are up after Wolfe Research upgraded the stock to Peer Perform from Underperform without a price target. Shares surged nearly 180% to $174.38 on Aug. 19, after a late-stage trial showed a treatment combining Moderna and Merck's experimental vaccine, intismeran autogene, and Merck's…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.